Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats

Pain

Volumn 86, Issue 1-2, 2000, Pages 185-194

  Malan, T Philip ^a,b   Ossipov, Michael H ^b   Gardell, Luis R ^b   Ibrahim, Mohab ^a,b   Bian, Di ^b   Lai, Josephine ^b   Porreca, Frank ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Extraterritorial neuropathic pain; Nerve injured rats; Spinal dynorphin

Indexed keywords

ANTISERUM; DIZOCILPINE; DYNORPHIN; DYNORPHIN A;

ALLODYNIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; IMMUNOASSAY; LUMBOSACRAL PLEXUS; MALE; NERVE INJURY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANESTHETICS, LOCAL; ANIMALS; ANTIBODIES, BLOCKING; DIZOCILPINE MALEATE; DYNORPHINS; EXCITATORY AMINO ACID ANTAGONISTS; HEAT; HYPERALGESIA; IMMUNOASSAY; LIDOCAINE; LIGATION; MALE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SPINAL NERVES;

EID: 0034193926     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00243-8     Document Type: Article

References (56)

1. Bakshi R., Faden A.I. Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects. Neurosci Lett. 110:1990;113-117.
2. Bakshi R., Faden A.I. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res. 507:1990;1-5.
3. Bian D., Ossipov M.H., Malan T.P., Porreca F. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci Lett. 241:1998;79-82.
4. Caudle R.M., Isaac L. A novel interaction between dynorphin(1-13) and N-methyl-d-aspartate. Brain Res. 443:1988;329-332.
5. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:1994;55-63.
6. Chen L., Gu Y., Huang L.-Y.M. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J Neurosci. 15:1995;4602-4611.
7. Chen L., Gu Y., Huang L.Y. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J Physiol. 482:1995;575-581.
8. Cho H.J., Basbaum A.I. Increased staining of immunoreactive dynorphin cell bodies in the deafferented spinal cord of the rat. Neurosci Lett. 84:1988;125-130.
9. Cox B.M., Molineaux C.J., Jacobs T.P., Rossenberger J.G., Faden A.I. Effects of traumatic injury on dynorphin immunoreactivity in spinal cord. Neuropeptides. 5:1985;571-574.
10. Davies S.N., Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res. 424:1987;402-406.
11. Devor M., Keller C.H., Ellisman M.H. Spontaneous discharge of afferents in a neuroma reflects original receptor tuning. Brain Res. 517:1990;245-250.
12. Devor M., Wall P.D., Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain. 48:1992;261-268.
13. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 26:1987;1235-1238.
14. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 20:1980;441-462.
15. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560:1991;186-192.
16. Faden A.I. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann Neurol. 27:1990;67-74.
17. Faden A.I., Jacobs T.P. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. Br J Pharmacol. 81:1984;271-276.
18. Gracely R.H., Lynch S.A., Bennett G.J. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain. 51:1992;175-194.
19. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
20. Kajander K.C., Sahara Y., Iadarola M.J., Bennett G.J. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides. 11:1990;719-728.
21. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
22. 2-17 to the NMDA receptor complex. Soc Neurosci Abstr. 23:1997;941.
23. Lai S.L., Gu Y., Huang L.Y. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons. Neurosci Lett. 247:1998;115-118.
24. Lee Y.-W., Chaplan S.R., Yaksh T.L. Systemic and supraspinal but not spinal opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett. 199:1995;111-114.
25. Lekan H.A., Carlton S.M., Coggeshall R.E. Sprouting of A beta fibers into lamina II of the rat dorsal horn in peripheral neuropathy. Neurosci Lett. 208:1996;147-150.
26. Long J.B., Skolnick P. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur J Pharmacol. 261:1995;295-301.
27. Long J.B., Petras J.M., Mobley W.C., Holaday J.W. Neurological dysfunction after intrathecal injection of dynorphin A(1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor sensory and autonomic function. J Pharmacol Exp Ther. 246:1988;1167-1174.
28. Long J.B., Rigamonti D.D., Oleshansky M.A., Wingfield C.P., Martinez-Arizala A. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J Pharmacol Exp Ther. 269:1994;358-366.
29. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
30. Nichols M.L., Bian D., Ossipov M.H., Malan T.P. Jr, Porreca F. Antiallodynic effects of a CCKB antagonist in rats with nerve ligation injury: role of endogenous enkephalins. Neurosci Lett. 215:1996;161-164.
31. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A(1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain. 69:1997;317-322.
32. Ossipov M.H., Nichols M.L., Bian D., Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci Lett. 199:1995;83-86.
33. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett. 199:1995;87-90.
34. Ossipov M.H., Lai J., Malan T.P., Porreca F. Kalso E., McQuay J.J., Wiesenfeld-Hallin Z. Opioid analgesic activity in neuropathic pain states. 1999;IASP Press, Seattle, WA.
35. Ossipov M.H., Bian D., Malan T.P., Lai J., Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain. 79:1999;127-133.
36. Pertovaara A. A neuronal correlate of secondary hyperalgesia in the rat spinal dorsal horn is submodality selective and facilitated by supraspinal influence. Exp Neurol. 149:1998;193-202.
37. Przewlocki R., Shearman G.T., Herz A. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats. Neuropeptides. 3:1983;233-240.
38. Ren K., Dubner R. NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw. Neurosci Lett. 163:1993;22-26.
39. Ren K., Hylden J.L., Williams G.M., Ruda M.A., Dubner R. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 50:1992;331-344.
40. Seltzer Z., Cohn S., Ginzburg R., Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain. 45:1991;69-75.
41. Sher G.D., Mitchell D. N-methyl-D-aspartate receptors mediate responses of rat dorsal horn neurones to hindlimb ischemia. Brain Res. 522:1990;55-62.
42. Sotgiu M.L., Biella G., Lacerenza M. Injured nerve block alters adjacent nerves' spinal interaction in neuropathic rats. NeuroReport. 7:1996;1385-1388.
43. Stevens C.W., Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J Pharmacol Exp Ther. 238:1986;833-838.
44. Stewart P., Isaac L. A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex. Brain Res. 543:1991;322-326.
45. Sung B., Na H.S., Kim Y.I., Yoon Y.W., Han H.C., Nahm S.H., Hong S.K. Supraspinal involvement in the production of mechanical allodynia by spinal nerve injury in rats. Neurosci Lett. 246:1998;117-119.
46. Swett J.E., Woolf C.J. The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord. J Comp Neurol. 231:1985;66-77.
47. Tal M., Bennett G.J. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of the uninjured nerve. Pain. 57:1994;375-382.
48. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P., Porreca F. Single intrathecal injections of dynorphin A or des-tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain. 68:1996;275-281.
49. Wagner R., Deleo J.A. Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury. Neuroscience. 72:1996;527-534.
50. Walker J.M., Katz R.J., Akil H. Behavioral effects of dynorphin 1-13 in the mouse and rat: initial observations. Peptides. 1:1980;341-345.
51. Walker J.M., Moises H.C., Coy D.H., Baldrighi G., Akil H. Nonopiate effects of dynorphin and des-tyr-dynorphin. Science. 218:1982;1136-1138.
52. Wegert S., Ossipov M.H., Nichols M.L., Bian D., Vanderah T., Malan T.P., Porreca F. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain. 71:1997;57-64.
53. Wilcox G.L. Excitatory neurotransmitters and pain. Bond M.R., Woolf C.J. Proceedings of the V1th World Congress on Pain. 1991;97-117 Elsevier, Amsterdam.
54. Woolf C.J., Shortland P., Reynolds M., Ridings J., Doubell T., Coggeshall R.E. Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy. J Comp Neurol. 360:1995;121-134.
55. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.
56. Zhang L., Peoples R.W., Oz M., Harvey-White J., Weight F.F., Brauneis U. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations. J Neurophysiol. 78:1997;582-590.